ALFATHON: One Spanish and two Italian teams in the final
The nomination of the Alfathon finalists took place during the first appointment with the INNOVATION TALKS, the Clubhouse room dedicated to technological innovation and health. ...
Read moreThe nomination of the Alfathon finalists took place during the first appointment with the INNOVATION TALKS, the Clubhouse room dedicated to technological innovation and health. ...
Read moreThe United Nations marks April 21st as the World Creativity and Innovation Day. For that reason, Alfasigma launches INNOVATION TALKS, a Clubhouse room focused on innovation technologies and health....
Read moreThe new corporate Alfasigma Russia website is online (https://ru.alfasigma.com/). This new website meets most modern technical requirements, has a striking design and a very user friendly interface....
Read moreThe ideas contest launched by Alfasigma at the beginning of November 2020 concluded the phase relating to the development and delivery of projects by the participants on January 6th. Alfathon collecte...
Read more3 challenges: from chemistry to software, from technologies to devices to support therapies. The award ceremony scheduled for 2021 at the Alfasigma Pomezia plant. ...
Read moreThree challenges to contribute to pharmaceutical research and innovation. Final prize of 5,000 euros for those who propose the best project. All projects will be evaluated for a further development....
Read moreMarino Golinelli turns 100, but his is not a birthday like many. Hundreds of greetings from employees, friends and ordinary people have arrived from all over the world. ...
Read moreOn Wednesday 8 July, the Private Assembly of Farmindustria appointed the new Presidential Committee for the two-year period 2020-2022....
Read moreAlfasoxx (Esoxx) has been awarded the Platinum Ounce (the most prestigious award on the Russian pharmaceutical market) “For the change of treatment paradigm"....
Read moreAnother way to interact and keep informed about Alfasigma....
Read moreYou’re entering Alfasigma global website
I agree